Concepedia

Ashley Adile

AA

6

Publications

358

Citations

6

H-Index

2018

Active since

Affiliations

University of Toronto(Current)

McMaster University

University of Calgary

Ashley Adile is an author at University of Toronto specializing in medicine, tumor biology, and cancer therapeutics.

Top concepts

MedicineGliomaPathologyTumor BiologyCancer TherapyNeuro-oncologyOncologyImmunologyPharmacologyImmunotherapy

Publications per year

2018–2022

6

Publications

6

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Parvez Vora, Chitra Venugopal, Sabra K. Salim et al. · Cell stem cell · 2020 · 179 citations · Full text

Neuro-oncology, Rational Development, Immunology +6

Wnt activation as a therapeutic strategy in medulloblastoma

Branavan Manoranjan, Chitra Venugopal, David Bakhshinyan et al. · Nature Communications · 2020 · 49 citations · Full text

BMI1 is a therapeutic target in recurrent medulloblastoma

David Bakhshinyan, Chitra Venugopal, Ashley Adile et al. · Oncogene · 2018 · 43 citations

Hematological Malignancy, Neuro-oncology, Pathology +3

Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer

Andrew E. Shouksmith, Fenil Shah, Michelle Grimard et al. · Journal of Medicinal Chemistry · 2019 · 36 citations · Full text

Hdac Inhibitors, Pathology, Hdac Drug +16

Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma

Nabanita Nawar, Shazreh Bukhari, Ashley Adile et al. · Journal of Medicinal Chemistry · 2022 · 29 citations · Full text

Rows per page

1–5 of 6